跳至主要内容
临床试验/CTRI/2018/03/012481
CTRI/2018/03/012481已完成3 期

Single Arm study to evaluate Efficacy and Safety of Oral Tracnil in patients of PCOS with Associated symptoms of Mild to Moderate Acne and Hirsutism

Curatio Health Care I Pvt Ltd0 个研究点目标入组 30 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Female patients between age 18 to 45 years of age
  • 2.Presence of PCOS with associated symptoms of mild to moderate acne and hirsutism
  • 3.Patients with BMI >28 or Waist Hip Ratio >0.9
  • 4.Patients with 5-50 Non-inflammatory facial lesions, except in the nose region (comedo closed and open comedo -degree 1) and/or 10 to 50 inflammatory facial lesions, except in the nose region (papule and pustule -degree 2)
  • 5.Patients with Ferriman-Gallwey hirsutism score 7 to 20, with Mild to moderate Acne
  • 6.Euthyroid Status
  • 7.Patient must not be pregnant, nursing or intend to become pregnant during the study
  • 8.Patient must agree to practice a medically acceptable form of birth control.
  • 9.Ability to understand and consent to participate in this clinical study, expressed by signing the consent form
  • 10.Patient willing to participate by providing written informed consent

排除标准

  • 1.Any finding of clinical observation (clinical assessment / physical) that is interpreted by the investigator as a risk to safety or which may interfere with the effectiveness of the treatment and research of the participants in the clinical trial;
  • 2.Any laboratory examination found that the investigator considers as safety risk or that may interfere with the effectiveness of the treatment and research of the participants in the clinical trial;
  • 3.Patients already taking or requiring Hormonal Treatment during study duration
  • 4.Other condition causing ovulatory disorders or androgen excess as hyperprolactinaemia, hypothyroidism, adrenal hyperplasia and Cushingâ??s syndrome
  • 5.Known hypersensitivity to the drug components used during the study;
  • 6.Patients with Uncontrolled or poorly controlled Diabetes Mellitus (HbA1C >6.5)
  • 7.Patients with positive result for urinary beta human chorionic gonadotropin or gestation period or breastfeeding
  • 8.Patients in the reproductive age who do not agree touse acceptable contraception [intrauterinedevice (IUD), barrier methods and tubal ligation]; other than surgically sterile (bilateral oophorectomy or hysterectomy) or sexual abstinence or who have not yet initiated sexual activity;
  • 9.Presence of dermatoses related to diabetes mellitus (plantar ulcer, necrobiosis lipoid, annular granuloma, dermatophytosis, deep mycoses, bacterial infections, opportunistic infections)
  • 10.Presence of dermatological diseases in the test area (face): vitiligo, psoriasis, atopic dermatitis
  • 11.Participant with cyst or lump in the face region; other diseases or medications, according to the investigator, that would interfere directly in the results of the study or jeopardize the health of the participant.

研究者

发起方
Curatio Health Care I Pvt Ltd

相似试验